Daniel J Campbell

Daniel J Campbell is a strategic development director at Jabil Healthcare, specializing in genomics and molecular diagnostics. With a robust background in molecular diagnostics, they have successfully guided innovative products from concept to commercial launch while fostering solutions that address unmet needs in the IVD market. Previous roles include leadership positions at Roche, where they launched groundbreaking molecular systems and established new business models, and held strategic roles at QIAGEN and Nypro. Daniel's education includes executive leadership training at London Business School and ongoing studies in information technology, accounting, and finance at various institutions.